Advances in sleep medicine and research from SLEEP 2026
This episode of the VJNeurology Podcast showcases advances across insomnia, restless legs syndrome, narcolepsy, and sleep apnea from SLEEP 2026. Leading experts discuss updates to the American Academy...
10 Heinä 41min
AAN 2026 highlights: key trial updates across narcolepsy, movement disorders, Tourette syndrome & more!
This episode of the VJNeurology Podcast showcases key trial updates from the American Academy of Neurology Annual Meeting in Chicago, IL. Highlights include orexin receptor agonists for narcolepsy, AM...
5 Touko 32min
Pediatric sleep disturbances: impact, screening, and ongoing research
This episode of the VJNeurology Podcast features a discussion with Prof. Karen Spruyt, PhD, Université Paris Cité, INSERM, NeuroDiderot, Paris, on pediatric sleep disturbances. Prof. Spruyt shares her...
11 Maalis 27min
Updates in the prevention, diagnosis, and treatment of cluster headache
In this episode of the VJNeurology podcast, we are joined by Prof. Mona Nada, MBBCh, MD, Cairo University, Cairo, Egypt, to discuss updates in the prevention, diagnosis, and treatment of cluster heada...
15 Tammi 12min
The impact of climate change and temperature fluctuations on the management of epilepsy
This episode of the VJNeurology Podcast focuses on the impact of climate change and temperature fluctuations on the management of epilepsy. Anita Arsovska, MD, PhD, University “Ss Cyril and Methodius”...
5 Joulu 202520min
CAR T-cell therapy for multiple sclerosis: insights from a Phase I trial
In this episode of the VJNeurology Podcast, Jeffrey Dunn, MD, Stanford University School of Medicine, Palo Alto, CA, shares insights from a Phase I trial (NCT06138132) of CAR T-cell therapy for multip...
31 Loka 202522min
Gene therapy in Parkinson's disease and other neurological disorders: advances and future directions
In this episode of the VJNeurology Podcast, we’re joined by Krystof Bankiewicz, MD, PhD, The Ohio State University, Columbus, OH, to explore the evolving role of gene therapy in Parkinson’s disease an...
6 Elo 202518min
